Professor

Ian Frazer

AC FAA FTSE FAHMS FRS

Ian Frazer
Image Description
Dr Frazer has spent 15 years developing prophylactic and therapeutic vaccines, with particular focus on prevention and treatment of papillomavirus associated cervical cancer. He developed a virus like particle based vaccine for prevention of papillomavirus infection which has shown 100% efficacy in late stage international clinical trials. He also developed a therapeutic vaccine for cervical pre-cancer, which is in clinical trail in Australia, and has proven efficacious in a number of animal models. His basic research in tumour immunology has provided insight into the problems of inducing immunity to antigens expressed in somatic cells without associated inflammation.

Fields of research

32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3204 IMMUNOLOGY
    • 320409 Tumour Immunology
44 HUMAN SOCIETY
  • 4499 Other human society

For full list of research codes, please visit the ARC Website .

Expertise type

  • Immunology
  • Medical Sciences
  • Pathology
  • Virology

Please contact fellowship@science.org.au to request any updates to the data.

Related

Conversation with scientist

Professor Ian Frazer, immunologist

Ian Frazer, born in Glasgow in 1953, trained as a physician and immunologist before focusing on human papillomavirus (HPV) and its link to cervical cancer after moving to Australia. His groundbreaking work with Dr Jian Zhou led to the development of the HPV vaccine, and he now serves as CEO and Director of Research at the Translational Research Institute. Interviewed by Robyn Williams in 2008.
Image Description